We are now six months passed the EU FMD deadline and various organisations like EMVO have begun to ask the authorities to take out sanctions against companies that don’t comply with the FMD regulations. With a recent European report claiming that up to 30% of the 2D codes containing the DSCSA serial number failed to scan, late adopters must understand the business risk they are taking by not complying.
With some form of serialisation expected to cover 80% of the global drug supply by 2022, having a system that can meet stringent requirements outlined in the EU directive will certainly make any subsequent compliance procedure a simpler progression.
Bart Vansteenkiste, global life sciences sector manager for Domino Printing Sciences, highlights five steps that companies need to take to ensure accurate coding and marking.